Practice Management News

On Oct. 1, the U.S. health care system will begin to use the International Classification of Diseases 10th edition ─ it replaces the decades-old 9th edition. This represents the largest change in coding since the revision of evaluation and management CPT codes in 1992.

Researchers from Nanyang Technological University, Singapore, A*STAR Singapore Institute of Manufacturing Technology, Singapore, and the Houston Methodist Hospital Research Institute, Texas, are developing a new medical device to test liver toxicity that can provide results in 30 minutes, according to a press release.

New bipartisan legislation, the Reinvigorating Antibiotic and Diagnostic Innovation Act, which aims to combat the issue of antibiotic resistance, has been introduced into Congress, according to a press release.

In the Kangbuk Samsung Health Study, researchers in South Korea found that the longer a person sits down combined with limited physical activity, the more likely they will develop nonalcoholic fatty liver disease, according to newly published data.

Health Canada announced it is requesting input from clinicians and other healthcare professionals on proposed revisions to the labeling standard for nonprescription acetaminophen products, in an effort to encourage consumers to use them more safely, according to a press release from Health Canada.

Patients with primary Sjögren’s syndrome were at higher risk for hospitalization in the presence of hepatic involvement, vasculitis and high disease activity, according to recently published research.

Although the tax season is over, tax scammers work year-round. The Internal Revenue Service advises taxpayers to stay alert to protect themselves against new ways criminals trick them out of their money or personal information.

The Wistar Institute announced it has entered into a research collaboration with Spark Therapeutics Inc. to improve gene therapy treatments that target the liver through creating and managing immune responses to treatment, according to a press release.

Researchers have developed a 3-D device for replicating liver cells that could expedite drug testing, according to published findings in Biofabrication.

Researchers estimate that the 2015 maintenance-of-certification program from the American Board of Internal Medicine will generate considerable costs, primarily attributed to demands on physician time.